Trump administration preps executive order on price transparency as lawmakers converge — WSJ
In a political sphere where Republicans and Democrats can find little common ground, the pharma industry in general — and price transparency in particular — has presented a rare opportunity for bipartisan agreement.
A slew of transparency bills are winding their way through congressional circles, with authors from both sides of the political aisles. And now the Wall Street Journal reports that pharma Critic-in-Chief Donald Trump is prepping an executive order that would require that consumers have access to the rates that have been negotiated throughout the system.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.